Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2010
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/22/2010US7741286 kringle peptides; peptidase stabilized
06/22/2010US7741274 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
06/22/2010US7741269 Exendins and exendin agonists for weight reduction and obesity
06/22/2010US7741080 elucidate the functional mechanism of adipocyte hypertrophy-dependent suppression of adiponectin production; identifies factors that can increase the expression of adiponectin gene; provides adiponectin expression-inducing agents; metabolic or heart diseases
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2563325C Oral modified-release lozenges and their preparation method
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2448741C Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2441232C Method for producing vitamin b-enriched preparations from grasses
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2401593C Infusion packet with useful and decorative elements, support member, delivery system and method
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2290810C Linked maltodextrins and preparation process thereof
06/22/2010CA2277075C Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/17/2010WO2010068918A2 Novel targets for treatment of hypercholesterolemia
06/17/2010WO2010068913A2 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
06/17/2010WO2010068907A2 Compositions of proton pump inhibitors and insulin secretagogues, kits and methods of their use to treat diabetes
06/17/2010WO2010068728A2 Engineering functional tissue from cultured cells
06/17/2010WO2010068605A1 Novel polymorphic forms of 4-[(4-methoxyphenyl)methyl]-5-(trifluoromethyl)-1h-pyrazole-3-yl]4-deoxy-4-fluoro-beta-d-glucopyranoside including hydrates thereof and the preparations thereof
06/17/2010WO2010068414A2 Methods for treating obesity related disease
06/17/2010WO2010068105A1 Nutritional compositions with large lipid globule size
06/17/2010WO2010068103A1 Nutritional compositions with coated lipid globules
06/17/2010WO2010067355A1 Method of treatment of diseases using hoodia extracts
06/17/2010WO2010067339A2 Fusion protein capable of binding vegf-a and tnf-alpha
06/17/2010WO2010067251A1 Trace elements
06/17/2010WO2010067233A1 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir)
06/17/2010WO2010067136A1 Novel crystalline forms
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066901A2 Tetrahydrotriazine compounds for treating diseases associated with ampk activity
06/17/2010WO2010066852A1 Composition comprising isoflavones
06/17/2010WO2010066840A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
06/17/2010WO2010066687A2 Stabalized statin-comprising compositions
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010066636A1 Novel insulin analogues
06/17/2010WO2010066569A1 Modulation of infant fat mass
06/17/2010WO2010066326A1 Combination of insulin with triazine derivatives and its use for treating diabetes
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010WO2010028189A3 Compounds, compositions and methods of using same for modulating uric acid levels
06/17/2010WO2010028132A3 Novel choline cocrystal of epalrestat
06/17/2010WO2010025436A3 Nitrogen and sulfur-containing heterocycle derivatives
06/17/2010WO2010022313A3 Processes for the preparation of sglt2 inhibitors
06/17/2010WO2009140972A3 Modulation of the vps10p-domain receptors for the treatment of cardiovascular disease
06/17/2010US20100152305 Methods of treatment of hyperuricemia and associated disease states
06/17/2010US20100152295 Methods of reducing small, dense ldl particles
06/17/2010US20100152291 Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition
06/17/2010US20100152286 Method for Producing Fucoxanthin
06/17/2010US20100152275 Drug or Supplement Combination with Conjugated Linoleic Acid for Fat Loss in Mammals
06/17/2010US20100152271 Estrogen receptor modulators and uses thereof
06/17/2010US20100152268 Stable atorvastatin formulations
06/17/2010US20100152260 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152246 5-Oxoisoxazoles as inhibitors of lipases and phospholipases
06/17/2010US20100152241 Inhibitors of store operated calcium release
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010US20100152208 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/17/2010US20100152187 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152166 Compounds and methods for modulating fxr
06/17/2010US20100152161 Compositions for weight management
06/17/2010US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152156 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152151 Tgr5 modulators and methods of use therof
06/17/2010US20100152146 Topical Administration of Danazol
06/17/2010US20100152118 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100152111 Polymer-based sustained release device
06/17/2010US20100152107 Long-term feed - cancer patient
06/17/2010US20100152099 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
06/17/2010US20100151589 Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof
06/17/2010US20100151066 Composition for suppressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect
06/17/2010US20100151063 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level
06/17/2010US20100151058 Compositions for producing satiety
06/17/2010US20100151057 Medicinal herbal extract having anti-obesity effect
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151020 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100151002 Guggulphospholipid Methods and Compositions
06/17/2010US20100150937 Antagonists of pcsk9
06/17/2010US20100150914 Agonist trkb antibodies and uses thereof
06/17/2010US20100150893 Methods of organ regeneration
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 1298